Suppr超能文献

体外冲击波碎石术和内窥镜治疗慢性胰腺炎疼痛:一项假对照、随机试验。

Extracorporeal Shock-Wave Lithotripsy and Endoscopy for the Treatment of Pain in Chronic Pancreatitis : A Sham-Controlled, Randomized Trial.

机构信息

Department of Gastroenterology, Asian Institute of Gastroenterology, Hyderabad, Telangana, India (R.T., M.U., A.B., S.S., M.T., N.J., S.L., M.R., R.K., R.G., D.N.R.).

Centre for Pancreatic Diseases & Mech-Sense, Department of Gastroenterology, Aalborg University Hospital, Aalborg, Denmark (S.S.O., A.M.D.).

出版信息

Ann Intern Med. 2024 Jun;177(6):749-758. doi: 10.7326/M24-0210. Epub 2024 May 28.

Abstract

BACKGROUND

No randomized controlled trials have substantiated endoscopic decompression of the pancreatic duct in patients with painful chronic pancreatitis.

OBJECTIVE

To investigate the pain-relieving effect of pancreatic duct decompression in patients with chronic pancreatitis and intraductal stones.

DESIGN

24-week, parallel-group, randomized controlled trial (ClinicalTrials.gov: NCT03966781).

SETTING

Asian Institute of Gastroenterology in India from February 2021 to July 2022.

PARTICIPANTS

106 patients with chronic pancreatitis.

INTERVENTION

Combined extracorporeal shock-wave lithotripsy (ESWL) and endoscopic retrograde pancreatography (ERP) compared with sham procedures.

MEASUREMENTS

The primary end point was pain relief on a 0- to 10-point visual analog scale (VAS) at 12 weeks. Secondary outcomes were assessed after 12 and 24 weeks and included 30% pain relief, opioid use, pain-free days, questionaries, and complications to interventions.

RESULTS

52 patients in the ESWL/ERP group and 54 in the sham group were included. At 12 weeks, the ESWL/ERP group showed better pain relief compared with the sham group (mean difference in change, -0.7 [95% CI, -1.3 to 0] on the VAS;  = 0.039). The difference between groups was not sustained at the 24-week follow-up, and no differences were seen for 30% pain relief at 12- or 24-week follow-up. The number of pain-free days was increased (median difference, 16.2 days [CI, 3.9 to 28.5 days]), and the number of days using opioids was reduced (median difference, -5.4 days [CI, -9.9 to -0.9 days]) in the ESWL/ERP group compared with the sham group at 12-week follow-up. Safety outcomes were similar between groups.

LIMITATION

Single-center study and limited duration of follow-up.

CONCLUSION

In patients with chronic pancreatitis and intraductal stones, ESWL with ERP provided modest short-term pain relief.

PRIMARY FUNDING SOURCE

Asian Institute of Gastroenterology and Aalborg University Hospital.

摘要

背景

没有随机对照试验证实内镜下胰管减压对慢性胰腺炎疼痛患者有效。

目的

研究内镜下胰管减压对伴有胰管内结石的慢性胰腺炎患者的止痛效果。

设计

24 周平行组随机对照试验(ClinicalTrials.gov:NCT03966781)。

地点

印度亚洲胃肠病学研究所,2021 年 2 月至 2022 年 7 月。

参与者

106 例慢性胰腺炎患者。

干预

联合体外冲击波碎石术(ESWL)和内镜逆行胰胆管造影术(ERP)与假手术比较。

测量

主要终点为 12 周时 0-10 分视觉模拟评分(VAS)的疼痛缓解。次要结局在 12 周和 24 周时评估,包括 30%的疼痛缓解、阿片类药物使用、无痛天数、问卷调查和干预相关并发症。

结果

ESWL/ERP 组 52 例,假手术组 54 例。12 周时,ESWL/ERP 组的疼痛缓解优于假手术组(VAS 变化的平均差值,-0.7[95%CI,-1.3 至 0]; = 0.039)。在 24 周随访时,两组间的差异没有持续,在 12 周和 24 周随访时,30%的疼痛缓解也没有差异。ESWL/ERP 组无痛天数增加(中位数差值,16.2 天[CI,3.9 至 28.5 天]),阿片类药物使用天数减少(中位数差值,-5.4 天[CI,-9.9 至-0.9 天]),与假手术组相比,差异均有统计学意义。两组的安全性结局相似。

局限性

单中心研究和随访时间有限。

结论

在伴有胰管内结石的慢性胰腺炎患者中,ESWL 联合 ERP 可提供短暂的止痛效果。

主要资助来源

亚洲胃肠病学研究所和奥尔堡大学医院。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验